Home
Aurobindo Pharma Ltd 52 Week High

Aurobindo Pharma Ltd
NSE: AUROPHARMA
YEARHIGH
Key Highlights
- The 52 Week HIGH of Aurobindo Pharma Ltd is ₹ 1592 as of 21 Feb 25 .
Company Fundamentals for Aurobindo Pharma Ltd
Market Price of Aurobindo Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1115.45 |
20 Feb 2025 | 1120.85 |
19 Feb 2025 | 1136.3 |
18 Feb 2025 | 1164.05 |
17 Feb 2025 | 1170.05 |
14 Feb 2025 | 1129.8 |
13 Feb 2025 | 1180.05 |
12 Feb 2025 | 1145.2 |
11 Feb 2025 | 1146.8 |
10 Feb 2025 | 1176.8 |
Asset Value vs Market Value of Aurobindo Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Aurobindo Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aurobindo Pharma Ltd
Historical Net Profit of Aurobindo Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aurobindo Pharma Ltd
Aurobindo Pharma Ltd News Hub
Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
16 Aug 24
Eugia Pharma Specialities receives USFDA warning for Unit III
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
16 Aug 24
Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
12 Aug 24
Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
However, revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quar
Read more
07 Feb 25